Type 2 diabetes has now become a global health problem threatening the lives of millions of people. According to the latest Diabetes Atlas 5, released on 14th November 2011 by the International Diabetes Federation (IDF), there are currently 366 million people with diabetes globally and this is predicted to increase to 552 million by the year 2030 [1] . Unfortunately, type 2 diabetes is a silent disease. In the Chennai Urban and Rural Epidemiology Study (CURES), it was shown that the "Rule of Halves" is very much valid in the case of diabetes [2] just as in the case of hypertension [3] . Thus, half of those with type 2 diabetes in the community remain undiagnosed, of those diagnosed, less than half receive treatment and of those who take treatment, less than half have their diabetes under control [2] . One of the challenges for physicians and diabetologists therefore, is to detect undiagnosed type 2 diabetes in the community. Obviously, one way to do it is to screen everyone in the population for the disorder. In a country like India, however, this is not feasible due to sheer numbers of people with diabetes. According to the recent ICMR -INDIAB study, there are an estimated 62.4 million people with diabetes and 77 million people with pre-diabetes [4] . Hence the challenges of screening 1.2 billion Indians to identify all those with diabetes and pre-diabetes can well be imagined. There is therefore a need to develop simple tools to cost effectively identify type 2 diabetes in the population. This led to the establishment of several risk scores for diabetes such as the American Diabetes Association Risk Score [5] Finnish Diabetes Risk Score [6] , German Diabetes Risk Score [7] , Danish Diabetes Risk Score [8] Cambridge Risk Score [9] and the Spanish Risk Score [10] . Within India also different risk scores have been described based on population based studies [11, 12] . It has been shown that the Indian Diabetes Risk Score (IDRS) is useful not only to predict undiagnosed diabetes in the community [11] but also to predict incident diabetes [13] , to classify the type of diabetes [14] and even to predict individuals who may have certain complications of diabetes like peripheral vascular disease and neuropathy [15] . The IDRS also serves as an effective indicator of metabolic syndrome and cardiovascular risk even among subjects with normal glucose tolerance [16] . Use of IDRS is more effective and less expensive than genotyping and makes it less costly than universal OGTT screening of the whole population to detect subjects with type 2 diabetes in India [17] . Thus it is clear that diabetes risk scores have come to stay, and if used judiciously, can lead to cost effective screening of diabetes.
While insulin secretory defects are common in all forms of diabetes, insulin resistance remains its hallmark of type 2 diabetes [18] . Several authors have tried to describe simple tools to predict insulin resistance in the community. In this issue of IJDDC, Srisung et al [19] Thailand Ministry of Public Health criteria is also on similar lines. Using such sophisticated systems including laboratory investigations does not appear to be suitable for mass screening for diabetes or insulin resistance. However, the Aekplakorn and the Keesukpham criteria are much simpler and are based on simple anthropometry and historical details and hence would be much more cost effective. It is to be appreciated that the Aekplakorn criteria, in spite of not including biochemical details such as HDL cholesterol, triglycerides or IFG or IGT, performs better than the other scores. The study by Srisung et al is therefore a valuable contribution to the existing knowledge on the subject. However, one of the issues with this study is the female excess (almost 81% of the subjects studied were females) which is a serious limitation as the applicability to males would need to be established further.
One of the guiding principles behind using risk scores, is that it must be simple and inexpensive so that it can be applied at a population level for public health workers. It should also be easy to use by non-medical people, if it is to gain wide acceptance. For research purposes, sophisticated tests for diagnosing insulin resistance such as the euglycemic clamp technique or the Frequently Sampled Intravenous Glucose Tolerance Test (FSIVGTT) remain the gold standard [20] . However these tests are laborious, require large volumes of blood to be drawn, are observer dependent and need specialized training. Hence they are clearly unsuitable for large scale screening for epidemiological or public health purposes. Hence simpler tools are necessary.
The use of fasting insulin and the homeostatic model assessment (HOMA -IR) have widely been used for epidemiological studies [21] . However, the insulin assay is expensive and also needs careful standardization. Finally, they are not useful for people who already have diabetes particularly if treated with insulin injections and they are therefore best applied in a non-diabetic population. Hence, the necessity of simple risk scores to predict insulin resistance. It is here, that the paper by Srisung et al [19] where they describe the usefulness of the Aekplakorn criteria to assess insulin resistance, becomes important. It is obvious that risk scores are ethnic specific [22] as they are derived from the populations in which they have been tested. Hence using the risk score described in one country or region for another ethnic group or another region of the world, may not be appropriate and each region should ideally have its own risk score.
Use of risk scores are particularly important as they can help to cost effectively screen for diabetes. We have shown that IDRS can help in cost effective screening for diabetes in India as it uses simple, safe and inexpensive measures. Moreover it would help to do selective screening instead of universal screening. For example, if we were to screen a population of 1,00,000 adults in a city using a 2 h post load plasma glucose, assuming the cost of one glucose estimation including blood collection to be Rs.30/-, the cost would work out to Rs.30,00,000. For the same population, if a two step procedure is used for screening for diabetes, i.e. use IDRS first and then screen only those likely to have diabetes, only 43% of the population who have a score ≥60, will have to be screened. This would capture over 72% of the undiagnosed diabetic subjects. If the screening test is carried out on all these individuals then the cost would work out to Rs.12,90,000. Even if we add a cost of Rs.1,50,000 for collecting information on IDRS, the overall cost would only work out to Rs.14,40,000. Thus there would be a cost saving of almost 50%, which in this case, is Rs.15,60,000. Thus, using IDRS would help to drastically reduce the costs of screening for diabetes at a community level [23] .
In summary, the use of simple clinical risk scores can help not only in cost effective screening for undetected type 2 diabetes, but also in its classification as well as to identify insulin resistance and metabolic syndrome in the community.
